{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:32:09Z","timestamp":1774038729536,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["856620"],"award-info":[{"award-number":["856620"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Cancer Society","award":["6-5156-32"],"award-info":[{"award-number":["6-5156-32"]}]},{"DOI":"10.13039\/100008376","name":"Helsinki University Central Hospital","doi-asserted-by":"crossref","award":["TYH 2019215, 2018306"],"award-info":[{"award-number":["TYH 2019215, 2018306"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["10-6623-11"],"award-info":[{"award-number":["10-6623-11"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Survival has improved in bladder cancer but few studies have considered extended periods or covered populations for which medical care is essentially free of charge. We analyzed survival in urothelial cancer (UC, of which vast majority are bladder cancers) in Finland and Sweden over a 50-year period (1967\u20132016) using data from the NORDCAN database. Finland and Sweden are neighboring countries with largely similar health care systems but higher economic resources and health care expenditure in Sweden. We present results on 1- and 5-year relative survival rates, and additionally provide a novel measure, the difference between 1- and 5-year relative survival, indicating how well survival was maintained between these two periods. Over the 50-year period the median diagnostic age has increased by several years and the incidence in the very old patients has increased vastly. Relative 1- year survival rates increased until early 1990s in both countries, and with minor gains later reaching about 90% in men and 85% in women. Although 5-year survival also developed favorably until early 1990s, subsequent gains were small. Over time, age specific differences in male 1-year survival narrowed but remained wide in 5-year survival. For women, age differences were larger than for men. The limitations of the study were lack of information on treatment and stage. In conclusion, challenges are to improve 5-year survival, to reduce the gender gap and to target specific care to the most common patient group, those of 70 years at diagnosis. The most effective methods to achieve survival gains are to target control of tobacco use, emphasis on early diagnosis with prompt action at hematuria, upfront curative treatment and awareness of high relapse requiring regular cystoscopy follow up.<\/jats:p>","DOI":"10.1371\/journal.pone.0261124","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T18:27:29Z","timestamp":1641320849000},"page":"e0261124","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-3316","authenticated-orcid":true,"given":"Kari","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akseli","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00f6rje","family":"Ljungberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"1","key":"pone.0261124.ref001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update","volume":"73","author":"M Roupret","year":"2018","journal-title":"Eur Urol"},{"issue":"6","key":"pone.0261124.ref002","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","article-title":"Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita","volume":"78","author":"JY Teoh","year":"2020","journal-title":"Eur Urol"},{"issue":"2","key":"pone.0261124.ref003","doi-asserted-by":"crossref","first-page":"153","DOI":"10.21037\/tau.2020.02.24","article-title":"Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030","volume":"9","author":"Q Cai","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"5","key":"pone.0261124.ref004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/JU.0000000000000025","article-title":"Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016","volume":"201","author":"H Ebrahimi","year":"2019","journal-title":"J Urol"},{"issue":"8","key":"pone.0261124.ref005","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","article-title":"The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015","volume":"118","author":"KF Brown","year":"2018","journal-title":"Br J Cancer"},{"key":"pone.0261124.ref006","volume-title":"GeneReviews((R))","author":"W Kohlmann","year":"1993"},{"key":"pone.0261124.ref007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/mutage\/gez022","article-title":"Genetic epidemiology of colorectal cancer and associated cancers","volume":"35","author":"H Yu","year":"2020","journal-title":"Mutagenesis"},{"issue":"6","key":"pone.0261124.ref008","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clgc.2019.07.011","article-title":"Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data","volume":"17","author":"JB Aragon-Ching","year":"2019","journal-title":"Clinical genitourinary cancer"},{"key":"pone.0261124.ref009","article-title":"Cancer risk in patients with type 2 diabetes mellitus and their relatives","author":"X Liu","year":"2015","journal-title":"Int J Cancer"},{"issue":"7","key":"pone.0261124.ref010","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database","volume":"67","author":"P M\u00f8ller","year":"2018","journal-title":"Gut"},{"issue":"1","key":"pone.0261124.ref011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/1055-9965.EPI-19-0213","article-title":"Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome","volume":"29","author":"JW Wischhusen","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2\u20133","key":"pone.0261124.ref012","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/02841860151116466","article-title":"A systematic overview of chemotherapy effects in urothelial bladder cancer","volume":"40","author":"S Nilsson","year":"2001","journal-title":"Acta Oncol"},{"issue":"4","key":"pone.0261124.ref013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/21681805.2019.1632380","article-title":"Incidence, survival and mortality trends of bladder cancer in Sweden 1997\u20132016","volume":"53","author":"PU Malmstrom","year":"2019","journal-title":"Scandinavian journal of urology"},{"key":"pone.0261124.ref014","article-title":"Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer","author":"AS Feldman","year":"2021","journal-title":"Urol Oncol"},{"issue":"1","key":"pone.0261124.ref015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE\u20145-a population-based study","volume":"15","author":"R De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"pone.0261124.ref016","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/02841860903575299","article-title":"Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964\u20132003 followed up to the end of 2006","volume":"49","author":"G Engholm","year":"2010","journal-title":"Acta Oncol"},{"key":"pone.0261124.ref017","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/annonc\/mdm413","article-title":"Influence of education level on cancer survival in Sweden","volume":"19","author":"SK Hussain","year":"2008","journal-title":"Ann Oncol"},{"issue":"15","key":"pone.0261124.ref018","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.ejca.2015.07.028","article-title":"Urinary tract cancer survival in Europe 1999\u20132007: Results of the population-based study EUROCARE-5","volume":"51","author":"R Marcos-Gragera","year":"2015","journal-title":"Eur J Cancer"},{"key":"pone.0261124.ref019","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12885-015-1161-9","article-title":"Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study","volume":"15","author":"M Kim","year":"2015","journal-title":"BMC Cancer"},{"issue":"14","key":"pone.0261124.ref020","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMsr1905447","article-title":"Epidemiologic Signatures in Cancer","volume":"381","author":"HG Welch","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0261124.ref021","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN\u2014a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"G Engholm","year":"2010","journal-title":"Acta Oncol"},{"issue":"5","key":"pone.0261124.ref022","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/02841861003631495","article-title":"Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964\u20132003 followed up to the end of 2006","volume":"49","author":"HH Storm","year":"2010","journal-title":"Acta Oncol"},{"issue":"5","key":"pone.0261124.ref023","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/02841861003739322","article-title":"Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964\u20132003 followed up to the end of 2006. Material and methods","volume":"49","author":"G Engholm","year":"2010","journal-title":"Acta Oncol"},{"issue":"3","key":"pone.0261124.ref024","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3322\/CA.2008.0001","article-title":"The staging of cancer: a retrospective and prospective appraisal","volume":"58","author":"FL Greene","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"pone.0261124.ref025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","article-title":"Guidelines on bladder cancer","volume":"41","author":"W Oosterlinck","year":"2002","journal-title":"Eur Urol"},{"issue":"2","key":"pone.0261124.ref026","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/bju.12242","article-title":"Development of renal cell carcinoma (RCC) diagnostics and impact on prognosis","volume":"113","author":"KL Sunela","year":"2014","journal-title":"BJU Int"},{"issue":"1","key":"pone.0261124.ref027","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clgc.2019.10.020","article-title":"Sex Differences in Urothelial Bladder Cancer Survival","volume":"18","author":"C Radkiewicz","year":"2020","journal-title":"Clinical genitourinary cancer"},{"issue":"9","key":"pone.0261124.ref028","doi-asserted-by":"crossref","first-page":"e016606","DOI":"10.1136\/bmjopen-2017-016606","article-title":"Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)","volume":"7","author":"C H\u00e4ggstr\u00f6m","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0261124.ref029","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/21681805.2015.1085089","article-title":"Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment","volume":"50","author":"S Jahnson","year":"2016","journal-title":"Scandinavian journal of urology"},{"issue":"5","key":"pone.0261124.ref030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update","volume":"76","author":"M Babjuk","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"pone.0261124.ref031","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines","volume":"79","author":"JA Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"23","key":"pone.0261124.ref032","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.21037\/atm-20-2108","article-title":"An overview of patients with urothelial bladder cancer over the past two decades: a Surveillance, Epidemiology, and End Results (SEER) study","volume":"8","author":"Y Zang","year":"2020","journal-title":"Ann Transl Med"},{"issue":"1","key":"pone.0261124.ref033","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.28397","article-title":"Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006","volume":"120","author":"ME Nielsen","year":"2014","journal-title":"Cancer"},{"issue":"3","key":"pone.0261124.ref034","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/21681805.2013.864698","article-title":"Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005\u20132010: a population-based study from the national Swedish kidney cancer register","volume":"48","author":"A Thorstenson","year":"2014","journal-title":"Scandinavian journal of urology"},{"key":"pone.0261124.ref035","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/ijc.27462","article-title":"Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry","volume":"131","author":"J Ji","year":"2012","journal-title":"Int J Cancer"},{"issue":"6","key":"pone.0261124.ref036","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0022-5347(01)66042-7","article-title":"Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group","volume":"155","author":"PU Malmstr\u00f6m","year":"1996","journal-title":"J Urol"},{"issue":"2","key":"pone.0261124.ref037","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1403494808100277","article-title":"Trends of tobacco use in Sweden and Finland: do differences in tobacco policy relate to tobacco use?","volume":"37","author":"K Patja","year":"2009","journal-title":"Scand J Public Health"},{"key":"pone.0261124.ref038","article-title":"Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis","author":"R Tellini","year":"2020","journal-title":"European urology oncology"},{"issue":"4","key":"pone.0261124.ref039","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2012.08.025","article-title":"Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer","volume":"63","author":"M Rink","year":"2013","journal-title":"Eur Urol"},{"key":"pone.0261124.ref040","article-title":"Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic","author":"K Hemminki","year":"2021","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"pone.0261124.ref041","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12885-021-08371-w","article-title":"Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff\/snus) as a possible risk factor","volume":"21","author":"K Hemminki","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"pone.0261124.ref042","doi-asserted-by":"crossref","first-page":"pkz036","DOI":"10.1093\/jncics\/pkz036","article-title":"Contemporary Associations of Exclusive Cigarette, Cigar, Pipe, and Smokeless Tobacco Use With Overall and Cause-Specific Mortality in the United States","volume":"3","author":"M Inoue-Choi","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"Suppl 1","key":"pone.0261124.ref043","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/eurpub\/cku102","article-title":"Cancer in immigrants as a pointer to the causes of cancer","volume":"24","author":"K Hemminki","year":"2014","journal-title":"European journal of public health"},{"issue":"4","key":"pone.0261124.ref044","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CEJ.0b013e3283387728","article-title":"Risk of transitional-cell carcinoma of the bladder in first- and second-generation immigrants to Sweden","volume":"19","author":"SM Mousavi","year":"2010","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"pone.0261124.ref045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/21681805.2017.1298156","article-title":"Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder","volume":"51","author":"G Jancke","year":"2017","journal-title":"Scandinavian journal of urology"},{"issue":"3","key":"pone.0261124.ref046","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/21681805.2018.1462254","article-title":"Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer","volume":"52","author":"C Sj\u00f6str\u00f6m","year":"2018","journal-title":"Scandinavian journal of urology"},{"issue":"6","key":"pone.0261124.ref047","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.eururo.2006.05.046","article-title":"Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature","volume":"50","author":"NM Fahmy","year":"2006","journal-title":"Eur Urol"},{"issue":"6","key":"pone.0261124.ref048","doi-asserted-by":"crossref","first-page":"e0253236","DOI":"10.1371\/journal.pone.0253236","article-title":"Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden","volume":"16","author":"K Hemminki","year":"2021","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T18:28:21Z","timestamp":1641320901000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261124"}},"subtitle":[],"editor":[{"given":"Klaus","family":"Roemer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0261124","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}